DiscoverTreating Blood CancersAdvancing Care in Myeloproliferative Neoplasms (MPNs)
Advancing Care in Myeloproliferative Neoplasms (MPNs)

Advancing Care in Myeloproliferative Neoplasms (MPNs)

Update: 2025-05-29
Share

Description


Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH














Recorded on May 13, 2025







Aaron Gerds, MD, MS
Aaron Gerds, MD, MS

Associate Professor of Medicine

Cleveland Clinic Lerner College of Medicine

Case Western Reserve University School of Medicine

Medical Director

Case Comprehensive Cancer Center Clinical Research Office

Cleveland, OH





In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs!











This episode is supported by GSK plc and Karyopharm Therapeutics.





Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Advancing Care in Myeloproliferative Neoplasms (MPNs)

Advancing Care in Myeloproliferative Neoplasms (MPNs)

Blood Cancer United